Serological Evidence of MERS-CoV and HKU8-related CoV Co-Infection in Kenyan Camels

Wei Zhang,Xiao Zheng,Bernard Agwanda,Sheila C. Ommeh,Kai Zhao,Jacqueline Kasiiti Lichoti,Ning Wang,Jing Chen,Bei Li,Xing‐Lou Yang,Shailendra Mani,Kisa-Juma Ngeiywa,Yan Zhu,Ben Hu,Samson Omondi Onyuok,Bing Yan,Danielle E. Anderson,Lin‐Fa Wang,Peng Zhou,Zhènglì Shí
DOI: https://doi.org/10.1080/22221751.2019.1679610
2019-01-01
Emerging Microbes & Infections
Abstract:Dromedary camels are important reservoir hosts of various coronaviruses, including Middle East respiratory syndrome coronavirus (MERS-CoV) that cause human infections. CoV genomes regularly undergo recombination during infection as observed in bat SARS-related CoVs. Here we report for the first time that only a small proportion of MERS-CoV receptor-binding domain positive (RBD) of spike protein positive camel sera in Kenya were also seropositive to MERS-CoV nucleocapsid (NP). In contrast, many of them contain antibodies against bat HKU8-related (HKU8r)-CoVs. Among 584 camel samples that were positive against MERS-CoV RBD, we found only 0.48 (8.22%) samples were also positive for NP. Furthermore, we found bat HKU8r-CoV NP antibody in 73 (12.5%) of the MERS-CoV RBD positive and NP negative samples, yet found only 3 (0.43%) of the HKU8r-CoV S1 antibody in the same samples. These findings may indicate co-infection with MERS-CoV and a HKU8r-CoV in camels. It may also raise the possibility of the circulation of a recombinant coronavirus virus with the spike of MERS-CoV and the NP of a HKU8r-CoV in Kenya. We failed to find molecular evidence of an HKU8r-CoV or a putative recombinant virus. Our findings should alert other investigators to look for molecular evidence of HKU8r-CoV or recombinants.
What problem does this paper attempt to address?